Are KIR-HLA polymorphisms relevant for the outcome of chronic infected hepatitis C virus patients?

Larisa Denisa Ursu^1,2, Carmen Monica Preda^1,3, Mircea Diculescu^1,2 and Ileana Constantinescu^1,2*

¹Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

²Centre for Immunogenetics and Virology, Fundeni Clinical Institute, Bucharest, Romania

³Department of Gastroenterology & Hepatology, Fundeni Clinical Institute, Bucharest, Romania

^*Corresponding Author: Ileana Constantinescu, Centre for Immunogenetics and Virology, Fundeni Clinical Institute, Bucharest, Romania, Tel: +40213180448 Email: